Anupam Rasayan To Acquire Up to 43% Stake In Bliss GVS Pharma For Around Rs 1,369 Crore

The acquisition will be funded through a Rs 300 crore term loan, with the remaining amount financed via a non-controlling, non-voting equity instrument.